erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
McCulloch AJ et al. Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis. 1985 Thorax pmid:4023983
Johnsson H and Niklasson PM Effects of some antibiotics of platelet function in vitro and in vivo. 1977 Thromb. Res. pmid:905975
Itoh T and Kasahara S Rat T lymphocyte progenitors in bone marrow can be induced to express more Thy 1. 1985 Thymus pmid:2865831
Bergan T [Erythromycin instead of tetracyclines to children]. 1978 Tidsskr. Nor. Laegeforen. pmid:684704
Høye S An extraordinary tale of an ordinary case. 2015 Tidsskr. Nor. Laegeforen. pmid:26130550
Loose LM et al. Adolescent with respiratory impairments and short-lived fever. 2015 Tidsskr. Nor. Laegeforen. pmid:26130549
Halstensen A et al. [Treatment of infections caused by group A beta-hemolytic streptococci]. 1990 Tidsskr. Nor. Laegeforen. pmid:2120791
Gulbrandsen P and Fugelli P [Bad custom]. 1991 Tidsskr. Nor. Laegeforen. pmid:2000597
Nesbakken T et al. [Chlamydial inclusion conjunctivitis in the newborn. 5 cases]. 1982 Tidsskr. Nor. Laegeforen. pmid:7157283
Ose L [Encephalitis associated with mycoplasma pneumoniae infection in children]. 1975 Tidsskr. Nor. Laegeforen. pmid:1145545
Lind O and Harthug S [Hearing loss after erythromycin therapy]. 1993 Tidsskr. Nor. Laegeforen. pmid:8211901
Brauteset LV et al. [Invasive pneumoccal disease in children in Oslo 1998-2004]. 2008 Tidsskr. Nor. Laegeforen. pmid:18552897
Aas K [Treatment of infections in allergic patients]. 1974 Tidsskr. Nor. Laegeforen. pmid:4820866
Volden G [Syphilis]. 1980 Tidsskr. Nor. Laegeforen. pmid:6992342
Lefsaker L et al. [Legionnaires' disease]. 1988 Tidsskr. Nor. Laegeforen. pmid:3353900
Holst-Larsen L [Antibacterial agents. 4. Erythromycin]. 1972 Tidsskr. Nor. Laegeforen. pmid:4657026
Hassel B [Acute hypothermia and adverse effects on the central nervous system during erythromycin therapy]. 1994 Tidsskr. Nor. Laegeforen. pmid:7915859
Afset JE and Maeland JA [Erythromycin and ciprofloxacin resistant Campylobacter jejuni]. 2001 Tidsskr. Nor. Laegeforen. pmid:11571989
Devriese L [Antibiotic sensitivity tests (author's transl)]. 1976 Tijdschr Diergeneeskd pmid:827819
Boswinkel M and Sloet van Oldruitenborgh-Oosterbaan MM [Diagnosis and therapy of Rhodococcus equi infection in the horse]. 2006 Tijdschr Diergeneeskd pmid:16989420
van der Toorn F and Lumeij JT [Streptococcus gallolyticus infections in racing pigeons, a literature review]. 2001 Tijdschr Diergeneeskd pmid:11227399
Schurgers M et al. [A case of toxic hepatitis]. 1974 Tijdschr Gastroenterol pmid:4454054
van der Lely N et al. [A child with Chlamydia trachomatis pneumonia]. 1993 Tijdschr Kindergeneeskd pmid:8266317
van der Kuy A et al. [The erythromycin group]. 1974 Tijdschr Ziekenverpl pmid:4499128
Ramos CJ and Antonetti DA The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers. 2017 Tissue Barriers pmid:28632993
Onodera T et al. Effect of fluid and antibiotic administration on experimental fecal peritonitis. 1968 Tohoku J. Exp. Med. pmid:5715596
Kanemitsu K et al. Efficacy of amikacin combinations for nocardiosis. 2003 Tohoku J. Exp. Med. pmid:14649737
Hara T et al. Successful treatment of severe reflux esophagitis with erythromycin in a patient with progressive systemic sclerosis and proximal gastrectomy. 2006 Tokai J. Exp. Clin. Med. pmid:21302226
Partiarca PA et al. Outbreaks of pertussis in the United States: the Wisconsin experience. 1988 Tokai J. Exp. Clin. Med. pmid:3273611
MUNOZBLAZQUEZ J [ANTIBIOTIC-CORTISONE TREATMENT OF GENITAL INFLAMMATION]. 1964 Tokoginecol Pract pmid:14108914
Giuliano MW and Miller SJ Site-Selective Reactions with Peptide-Based Catalysts. 2016 Top Curr Chem pmid:26307403
DUBRA F [PATHOLOGY OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. 1963 Sep-Dec Torax pmid:14158172
DUBRA F [THE CURE OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. 1963 Sep-Dec Torax pmid:14158173
PALERMO FM [SECONDARY BACTERIAL RESISTANCE]. 1963 Sep-Dec Torax pmid:14159781
BARDIER A et al. [Results of infantile propiocine granulated for syrup in infections pathology in infants (Apropos of 71 cases)]. 1961 Toulouse Med pmid:13686911
BARDIER A et al. [CURRENT TREATMENT OF PLEURO-PULMONARY STAPHYLOCOCCAL INFECTIONS IN INFANTS (APROPOS OF 60 CASES)]. 1964 Toulouse Med pmid:14169371
Abdel-Hameid NA Protective role of dimethyl diphenyl bicarboxylate (DDB) against erythromycin induced hepatotoxicity in male rats. 2007 Toxicol In Vitro pmid:17267170
Tilmant K et al. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis. 2011 Toxicol In Vitro pmid:21515356
Peyre L et al. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity. 2015 Toxicol In Vitro pmid:26239606
Hayashi S et al. Characterization of multinuclear hepatocytes induced in rats by mitemcinal (GM-611), an erythromycin derivative. 2008 Toxicol Pathol pmid:18776165
Montenez JP et al. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. 1999 Toxicol. Appl. Pharmacol. pmid:10198278
Mahgoub A et al. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. 2005 Toxicol. Appl. Pharmacol. pmid:15885263
Gant TW et al. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. 1995 Toxicol. Appl. Pharmacol. pmid:7645023
Fujii E et al. Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study. 2008 Toxicol. Appl. Pharmacol. pmid:18355581
Dakhel Y and Jamali F Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction. 2006 Toxicol. Appl. Pharmacol. pmid:16466760
Dujovne CA Liver cell culture toxicity and surfactant potency of erythromycin derivatives. 1975 Toxicol. Appl. Pharmacol. pmid:1135866
Sadrieh N and Thomas PE Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. 1994 Toxicol. Appl. Pharmacol. pmid:8048065
WORTH HM et al. INTRAGASTRIC INJECTION FOR TOXICITY STUDIES WITH NEWBORN RATS. 1963 Toxicol. Appl. Pharmacol. pmid:14082477
Gray JE et al. Foam cell response in the lung and lymphatic tissues during long-term high-level treatment with erythromycin. 1978 Toxicol. Appl. Pharmacol. pmid:725925
Gaeta GB et al. Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. 1985 Toxicol. Appl. Pharmacol. pmid:2992120